Orthopediatrics (KIDS) Cash from Financing Activities (2016 - 2026)
Orthopediatrics' (KIDS) quarterly Cash from Financing Activities came in at -$614000.0 in Q1 2026, down 387.3% year-on-year from $213712.7 in Q1 2025, and down 47.24% on a QoQ basis from -$417000.0 in Q4 2025.
Orthopediatrics (KIDS) Cash from Financing Activities (2016 - 2026) Analysis & Trends
Orthopediatrics (KIDS) has 11 years of Cash from Financing Activities data on file, last reported at -$614000.0 in Q1 2026.
- On a quarterly basis, Cash from Financing Activities fell 387.3% year-over-year to -$614000.0 in Q1 2026; TTM through Mar 2026 was $23.5 million, a 56.17% decrease from a year earlier, with the FY2025 full-year figure at $24.0 million, down 54.88% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$614000.0, down from -$417000.0 in the prior quarter.
- Over the last five years, Cash from Financing Activities for KIDS reached as high as $108.3 million in Q3 2022 and fell as low as -$4.3 million in Q2 2024.
- Historically, Cash from Financing Activities has averaged $12.9 million across 5 years, with a median of -$36000.0 in 2023.
- On a YoY basis, Cash from Financing Activities climbed as much as 390220.0% in 2024 and fell as far as 1491.67% in 2024.
- Year by year, Cash from Financing Activities stood at -$35000.0 in 2022, then surged by 26920.0% to $9.4 million in 2023, then tumbled by 105.76% to -$541000.0 in 2024, then grew by 22.92% to -$417000.0 in 2025, then slumped by 47.24% to -$614000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were -$614000.0 in Q1 2026, -$417000.0 in Q4 2025, and -$282000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -25.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -26.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Orthopediatrics | 443.38 Mn | 429.14 Mn | 43.39 Mn | -614,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -614,000.00 |
| Mar 31, 2026 | -614,000.00 |
| Dec 31, 2025 | -417,000.00 |
| Dec 31, 2025 | -417,000.00 |
| Sep 30, 2025 | -282,000.00 |
| Sep 30, 2025 | -282,000.00 |
| Jun 30, 2025 | 24.80 Mn |
| Jun 30, 2025 | 24.80 Mn |
| Mar 31, 2025 | -126,000.00 |
| Mar 31, 2025 | -126,000.00 |
| Dec 31, 2024 | -541,000.00 |
| Dec 31, 2024 | -541,000.00 |
| Sep 30, 2024 | 58.52 Mn |
| Sep 30, 2024 | 58.52 Mn |
| Jun 30, 2024 | -4.27 Mn |
| Jun 30, 2024 | -4.27 Mn |
| Mar 31, 2024 | -573,000.00 |
| Mar 31, 2024 | -573,000.00 |
| Dec 31, 2023 | 9.39 Mn |
| Dec 31, 2023 | 9.39 Mn |